ChartMill assigns a Buy % Consensus number of 80% to PRTK. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-07-10 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-06-07 | Jefferies | Downgrade | Buy -> Hold |
| 2023-06-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-06 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-10 | WBB Securities | Upgrade | Buy -> Strong Buy |
| 2021-11-09 | HC Wainwright & Co. | Maintains | Buy |
| 2021-06-21 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-23 | WBB Securities | Upgrade | Speculative Buy -> Buy |
| 2021-03-02 | Jefferies | Initiate | Buy |
9 analysts have analysed PRTK and the average price target is 3.16 USD. This implies a price increase of 41.79% is expected in the next year compared to the current price of 2.23.
The consensus rating for PARATEK PHARMACEUTICALS INC (PRTK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PARATEK PHARMACEUTICALS INC (PRTK) is 9.